Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 66, Issue 11
Volume 66, Issue 11
1 June 2018
ISSN 1058-4838
EISSN 1537-6591

Volume 66, Issue 11, 1 June 2018

NEWS

Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages i–ii, https://doi.org/10.1093/cid/ciy226

IN THE LITERATURE

Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages iii–iv, https://doi.org/10.1093/cid/ciy360

ARTICLES AND COMMENTARIES

Sjoukje H S Woudt and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1651–1657, https://doi.org/10.1093/cid/cix1076

Antibiotic nonsusceptibility was consistently associated with higher risks of recurrent bacteremia, but the estimated number of additional recurrent episodes in the Netherlands (40 per year) was rather limited.

Shabir A Madhi and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1658–1665, https://doi.org/10.1093/cid/cix1088

Respiratory syncytial virus (RSV) infection was associated with respiratory illness during pregnancy and postpartum in women. Vaccination during pregnancy against RSV could benefit the mother, primarily against nonfebrile illness, and her infant.

Fernando P Polack
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1666–1667, https://doi.org/10.1093/cid/cix1091
Shino Arikawa and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1668–1677, https://doi.org/10.1093/cid/cix1102

Pooled results from 21 studies involving more than 19 000 human immunodeficiency virus–exposed but uninfected children show that an estimated two-thirds of infant deaths are attributable to lack of antiretroviral treatment for mothers, low birth weight, never being breastfed, and mother’s death.

Cornelius J Clancy and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1678–1686, https://doi.org/10.1093/cid/cix1095

T2Candida, a nanodiagnostic panel that detects Candida directly within whole blood, was 89% sensitive for diagnosing candidemia at the time of positive blood cultures. In patients who received antifungal therapy, T2Candida identified bloodstream infections that were missed by blood cultures.

H Bradford Hawley
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1687–1688, https://doi.org/10.1093/cid/cix1101
Babafemi O Taiwo and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1689–1697, https://doi.org/10.1093/cid/cix1083

Dolutegravir plus lamivudine was virologically effective and safe in treatment-naive individuals with human immunodeficiency virus type 1 RNA up to 500 000 copies/mL. A participant who experienced failure developed the M184V lamivudine and the R263R/K integrase resistance mutations.

Yoichiro Natori and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1698–1704, https://doi.org/10.1093/cid/cix1082

This randomized trial demonstrates superior immunogenicity of high-dose influenza vaccine compared to standard-dose trivalent vaccine in immunosuppressed organ transplant recipients. High doses of mycophenolate were associated with reduced immunogenicity.

Yafet Mamo and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1705–1711, https://doi.org/10.1093/cid/cix1097

A total of 137 patients were contacted after fecal microbiota transplantation (FMT) for recurrent Clostridium difficile infection. At median 22 months follow-up, 82% were free of C. difficile recurrence and 95% would undergo FMT if they had recurrent C. difficile.

Robert M Grant and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1712–1721, https://doi.org/10.1093/cid/cix1086

Daily PrEP dosing recommendations led to a greater likelihood of protective drug concentrations in the Harlem cohort of men and transgender women who have sex with men, while daily and nondaily regimens led to comparably favorable outcomes in Bangkok.

Michael Rickles and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1722–1732, https://doi.org/10.1093/cid/cix1079

We examined whether more granular data improved insights into county-level HIV/hepatitis C virus (HCV) outbreak vulnerability in Tennessee relative to recent national models. Sixteen counties unranked in prior analyses were identified as vulnerable. Importantly, opioid prescribing patterns significantly influenced increased risk for HIV/HCV.

François Rouet and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1733–1741, https://doi.org/10.1093/cid/cix1071

This study provided the serologic, genomic, and geospatial investigation of an iatrogenic outbreak that was recognized in rural Cambodia in 2014–2015, showing a massive and spatially localized outbreak of HIV, associated with HCV infections, but a lack of HBV diffusion.

Zobair M Younossi and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1742–1750, https://doi.org/10.1093/cid/cix1106

Treatment of hepatitis C virus with the new direct-acting antivirals in patients with minimal or no hepatic fibrosis provides not only high rates of cure but also significant improvement in patient-reported outcomes (quality of life, fatigue, and work productivity).

Eyal Meltzer and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1751–1755, https://doi.org/10.1093/cid/cix1077

In rafters to the Omo River, Ethiopia, atovaquone-proguanil provides causal (liver-schizont stage) prophylaxis for Plasmodium vivax but is ineffective against late, hypnozoite-reactivation-related attacks. Primaquine is the chemoprophylaxis agent of choice in areas where Plasmodium falciparum and Plasmodium vivax co-circulate.

Adamma Mba-Jonas and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1756–1761, https://doi.org/10.1093/cid/cix1094

A multistate outbreak of Salmonella Agona was investigated in 2011. Through the combined use of interviews to identify suspect food vehicles, traceback, and novel techniques for analyzing distribution records, papayas from Mexico were identified as the source of the outbreak.

Antoine Moulignier and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1762–1769, https://doi.org/10.1093/cid/cix1075

Cerebral small-vessel disease was detected in 52% of middle-aged HIV-infected individuals with long-term viral suppression and 36% of frequency age- and sex-matched uninfected controls, with an adjusted odds ratio of 2.3 (95% confidence interval, 1.5–3.6).

Nava Yeganeh and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1770–1777, https://doi.org/10.1093/cid/cix1104

More than 10% of previously untreated HIV-infected pregnant women and their infants had clinically significant antiretroviral drug-associated resistance mutations. Drug-related mutations did not appear to increase the risk of HIV transmission, but were transmitted to infants.

Sharon A Greene and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1778–1784, https://doi.org/10.1093/cid/cix1096

Human immunodeficiency virus (HIV)–infected women with cervical intraepithelial neoplasia 2/3 randomized to loop electrosurgical excision procedure (LEEP) had higher mean cervical HIV RNA at 2 and 3 weeks after intervention compared to women treated with cryotherapy. Cervical HIV shedding after LEEP occurred both on and off antiretroviral therapy.

Guillemette Unal and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1785–1793, https://doi.org/10.1093/cid/cix1087

Our study shows that HIV-1 group O infection could have a milder natural evolution relative to HIV-1 group M, and that its current therapeutic management (excluding use of nonnucleoside reverse transcriptase inhibitor–based regimens), is highly efficient despite the genetic divergence of group O variants.

BRIEF REPORTS

Babafemi O Taiwo and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1794–1797, https://doi.org/10.1093/cid/cix1131
Sylvia M LaCourse and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1798–1801, https://doi.org/10.1093/cid/ciy011

REVIEW ARTICLE

Pearlie P Chong and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1802–1811, https://doi.org/10.1093/cid/cix1081

A booster-dose influenza vaccination strategy could improve immunogenicity in transplant recipients. Injection site reactions were more commonly observed in transplant recipients who received alternative influenza vaccination strategies.

PHOTO QUIZ

Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Page 1812, https://doi.org/10.1093/cid/cix1073

ANSWER TO THE PHOTO QUIZ

María Ángeles Meléndez-Carmona and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1813–1814, https://doi.org/10.1093/cid/cix1074

CORRESPONDENCE

Rita Murri and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1815–1816, https://doi.org/10.1093/cid/cix1114
James R Johnson
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1816–1817, https://doi.org/10.1093/cid/cix1146
Emily S Spivak and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Page 1817, https://doi.org/10.1093/cid/cix1149
Gaston De Serres and Danuta M Skowronski
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1817–1818, https://doi.org/10.1093/cid/ciy014
Shungo Yamamoto and Sho Nishimura
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Page 1819, https://doi.org/10.1093/cid/ciy017
Torgny Sunnerhagen and Magnus Rasmussen
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1819–1820, https://doi.org/10.1093/cid/ciy021
Peter J Veldkamp and others
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Pages 1820–1821, https://doi.org/10.1093/cid/ciy015

BOOK REVIEW

Habiba Hassouna and Abhishek Deshpande
Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Page 1822, https://doi.org/10.1093/cid/cix1148

COVER

Clinical Infectious Diseases, Volume 66, Issue 11, 1 June 2018, Page NP, https://doi.org/10.1093/cid/ciy368
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close